Are the new guidelines for cholesterol and hypertension age friendly?

Journal of the American Medical Directors Association

Volumn 15, Issue 6, 2014, Pages 373-375

  Sanford, Angela ^a   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; DRUG MEGADOSE; EDITORIAL; HUMAN; HYPERTENSION; META ANALYSIS (TOPIC); MYOPATHY; NURSING HOME PATIENT; PRACTICE GUIDELINE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); AGED; BLOOD; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FRAIL ELDERLY; GERIATRICS; NURSING HOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; CORONARY ARTERY DISEASE; FRAIL ELDERLY; GERIATRICS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; NURSING HOMES; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84901481943     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.04.001     Document Type: Editorial

References (68)

1. Stone N., Robinson J., Lichtenstein A.H., et al. 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic heart risk in adults: A report of the American College of Cardiology/American Heart Association task Force on Practice Guidelines. JAm Coll Cardiol 2013, [Epub ahead of print]. 10.1016/j.jacc.2013.11.002.
2. James P.A., Dennison-Himmelfarb C., LeFevre M.L., et al. 2014 Evidence-based guideline for the Management of high blood pressure in adults. Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014, 31:507-520.
3. Morley J.E. Caring for the vulnerable elderly: Are available quality indicators appropriate?. JAm Med Dir Assoc 2008, 9:1-3.
4. Morley J.E. Phronesis and the medical director. JAm Med Dir Assoc 2009, 10:149-152.
5. Pencina M.J., Navar-Boggan A.M., D'Agostino R.B., et al. Application of new cholesterol guidelines to a population-based sample. NEngl J Med 2014, 370:1422-1431.
6. Ridker P., Cook N. Statins: new American guidelines for prevention of cardiovascular disease. Lancet 2013, 382:1762-1765.
7. Stone N.J., Robinson J.G., Lichtenstein A.H., et al. 2013 ACC/AHA Cholesterol Guideline Panel. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: Synopsis of the 2013 ACC/AHA Cholesterol Guideline. Ann Inter Med 2014, 160:339-343.
8. Ioannidis J. More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. JAMA 2014, 311:463-464.
9. Morley J.E., Mahon G. Statins and the nursing home. JAm Med Dir Assoc 2013, 14:853-854.
10. Jacobs J.M., Cohen A., Ein-Mor E., Stessman J. Cholesterol, statins, and longevity from age 70 to 90 years. JAm Med Dir Assoc 2013, 14:883-888.
11. Levenson S.A., Morley J.E. Evidence rocks in long-term care, but does it roll?. JAm Med Dir Assoc 2007, 8:493-501.
12. Morley J.E. The cholesterol conundrum. JAM Geriatr Soc 2011, 59:1955-1956.
13. Joseph J., Koka M., Aronow W.S. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. JAm Med Dir Assoc 2008, 9:124-127.
14. Joseph J., Koka M., Aronow W.S. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home. JAm Med Dir Assoc 2008, 9:51-54.
15. Morley J.E., Banks W.A. Lipids and cognition. JAlzheimers Dis 2010, 20:737-747.
16. St-Pierre A.C., Cantin B., Dagenais G.R., et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular study. Arterioscler Throm Vasc Biol 2005, 25:553-559.
17. Arai H., Kokubo Y., Watanabe M., et al. Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: The Suita study. JAtheroscler Throm 2013, 20:195-203.
18. Lamarche B., St-Pierre A.C., Ruel I.L., et al. Aprospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol 2001, 17:859-865.
19. MacIntosh C., Morley J.E., Chapman I.M. The anorexia of aging. Nutrition 2000, 16:983-995.
20. Silver A.J., Morley J.E., Strome L., et al. Nutritional status in an academic nursing home. JAm Geriatr Soc 1988, 36:487-491.
21. Downs J., Good C. New cholesterol guidelines: Has Godot finally arrived?. Ann Int Med 2014, 160:354-356.
22. Chobanian A.V., Bakris G.L., Black H.R., et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003, 289:2560-2572.
23. Krumholz H.M. The new cholesterol and blood pressure guidelines: Perspective on the Path Forward. JAMA 2014, 311:1403-1405.
24. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264. SHEP Cooperative Research Group.
25. Staessen J.A., Fagard R., Thijs L., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757-764.
26. Morley J.E. Hypertension: Is it overtreated in the elderly?. JAm Med Dir Assoc 2010, 11:147-152.
27. Jacobs J.M., Stessman J., Ein-Mor E., Bursztyn M. Hypertension and 5-year mortality among 85-year-olds: The Jerusalem Longitudinal Study. JAm Med Dir Assoc 2012, 13:759.e1-759.e6.
28. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. NEngl J Med 2008, 358:1887-1898. HYVET Study Group.
29. Bulpitt C.J., Peters R., Staessen J.A., et al. Fracture risk and the use of a diuretic (indapamide SR) ± perindopril: A substudy of the Hypertension in the Very Elderly Trial (HYVET). Trial 2006, 7:33.
30. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. JAm Med Dir Assoc 2008, 9:71-72.
31. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
32. Lee J.S.W., Auyeung T.-W., Leung J., et al. Transitions in frailty states among community-living older adults and their associated factors. JAm Med Dir Assoc 2014, 15:281-286.
33. Rockwood K., Abeysundera M.J., Mitnitski A. How should we grade frailty in nursing home patients?. JAm Med Dir Assoc 2007, 8:595-603.
34. Shimada H., Makizako H., Doi T., et al. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. JAm Med Dir Assoc 2013, 14:518-524.
35. Morley J.E., Malmstrom T.K., Miller D.K. Asimple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. JNutr Health Aging 2012, 16:601-608.
36. Morley J.E. Frailty: Diagnosis and management. JNutr Health Aging 2011, 15:667-670.
37. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
38. Morley J.E. Clinical practice in nursing homes as a key for progress. JNutr Health Aging 2010, 14:586-593.
39. Tolson D., Rolland Y., Andrieu S., et al. The International Association of Gerontology and Geriatrics/World Health Organization/Society Française de Gérontologie et de Gériatrie Task Force. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. JAm Med Dir Assoc 2011, 12:184-189.
40. Rolland Y., de Souto Barreto P. Research can improve care in the nursing home. JAm Med Dir Assoc 2013, 14:233-235.
41. Welsh T., Gladman J., Gordon A.L. The treatment of hypertension in care home residents: A systematic review of observational studies. JAm Med Dir Assoc 2014, 15:8-16.
42. Morley J.E. Polypharmacy in the nursing home. JAm Med Dir Assoc 2009, 10:289-291.
43. Morandi A., Bellelli G., Vasilevskis E.E., et al. Predictors of rehospitalization among elderly patients admitted to a rehabilitation hospital: The role of polypharmacy, functional status, and length of stay. JAm Med Dir Assoc 2013, 14:761-767.
44. Onder G., Liperoti R., Foebel A., et al. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: Results from the SHELTER study. JAm Med Dir Assoc 2013, 14:450.e7-450.e12.
45. Little M.O., Morley A. Reducing polypharmacy: Evidence from a simple quality improvement initiative. JAm Med Dir Assoc 2013, 14:152-156.
46. Kojima G., Bell C., Tamura B., et al. Reducing cost by reducing polypharmacy: The polypharmacy outcomes project. JAm Med Dir Assoc 2012, 13:818.e11-818.e15.
47. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. JAm Med Dir Assoc 2011, 12:326-330.
48. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. JAm Med Dir Assoc 2010, 11:475-484.
49. Morley J.E. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
50. Tamura B.K., Bell C.L., Masaki K.H., Amella E.J. Factors associated with weight loss, low BMI, and malnutrition among nursing home patients: A systematic review of the literature. JAm Med Dir Assoc 2013, 14:649-655.
51. Soenen S., Chapman I.M. Body weight, anorexia, and undernutrition in older people. JAm Med Dir Assoc 2013, 14:642-648.
52. Morley J.E. Undernutrition: A major problem in nursing homes. JAm Med Dir Assoc 2011, 12:243-246.
53. Mossello E., Pieraccioli M.C., Zanieri S., et al. Ambulatory blood pressure monitoring in older nursing home residents: Diagnostic and prognostic role. JAm Med Dir Assoc 2012, 13:760.e1-760.e5.
54. Onen S.H., Lesourd B., Ouchchane L., et al. Occult nighttime hypertension in daytime normotensive older patients with obstructive sleep apnea. JAm Med Dir Assoc 2012, 13:752-756.
55. Morley J.E. Syncope. J Am Med Dir Assoc 2013, 14:311-312.
56. Iwanczyk L., Weintraub N.T., Rubenstein L.Z. Orthostatic hypotension in the nursing home setting. JAm Med Dir Assoc 2006, 7:163-167.
57. Khera S., Palaniswamy C., Aronow W.S., et al. Predictors of mortality, rehospitalization for syncope, and cardiac syncope in 352 consecutive elderly patients with syncope. JAm Med Dir Assoc 2013, 14:326-330.
58. Arbique D., Cheek D., Welliver M., Vongpatanasin W. Management of neurogenic orthostatic hypotension. JAm Med Dir Assoc 2014, 15:234-239.
59. Morley J.E., Rolland Y., Tolson D., Vellas B. Increasing awareness of the factors producing falls: The mini falls assessment. JAm Med Dir Assoc 2012, 13:87-90.
60. Maurer M.S., Cohen S., Cheng H. The degree and timing of orthostatic blood pressure changes in relation to falls in nursing home residents. JAm Med Dir Assoc 2004, 5:233-238.
61. Morley J.E. Frailty, falls, and fractures. JAm Med Dir Assoc 2013, 14:149-151.
62. Morley J.E. Hip fractures. JAm Med Dir Assoc 2010, 11:81-83.
63. Trahair L.G., Horowitz M., Jones K.L. Postprandial hypotension: A systematic review. JAm Med Dir Assoc 2014, 15:394-409.
64. Morley J.E. Editorial: Postprandial hypotension-The ultimate Big Mac attack. JGerontol A Biol Sci Med Sci 2001, 56:M742-M743.
65. Edwards B.J., Perry H.M., Kaiser F.E., et al. Relationship of age and calcitonin gene-related peptide to postprandial hypotension. Mech Ageing Dev 1996, 87:61-73.
66. Aronow W.S. Treatment of hypertension in the elderly. JAm Med Dir Assoc 2013, 14:847.
67. Aronow W.S. Hypertension in the nursing home. JAm Med Dir Assoc 2008, 9:486-490.
68. Supiano M.A. Healthy people aged 80 and older with systolic blood pressure greater than 10 mmHg should be treated. JAm Geriatr Soc 2013, 61:1199-1220.